• Explore /
  • Poster
  • / CD40 ligand/interferon-γ matured DC immunization with gp100 antigen HLA class I  A *0201 restricted peptides in patients with newly diagnosed metastatic melanoma.

CD40 ligand/interferon-γ matured DC immunization with gp100 antigen HLA class I  A *0201 restricted peptides in patients with newly diagnosed metastatic melanoma.

Abstract Poster

Authors

null

Gerald P. Linette

Washington University, St. Louis, MO

Gerald P. Linette , Michelle Becker-Hapak , Alexander Huang , Amer Alyasiry , Megan Chan , Wen-rong Lie , Lynn Cornelius , Jeffrey F. Moley , Rebecca Aft , Benjamin R. Tan Jr., Kathryn Trinkaus , Beatriz M Carreno

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Developmental Therapeutics - Clinical Pharmacology and Immunotherapy

Track

Developmental Therapeutics

Sub Track

Immunotherapy and Biologic Therapy

Clinical Trial Registration Number

NCT00683670

Citation

J Clin Oncol 30, 2012 (suppl; abstr 2525)

DOI

10.1200/jco.2012.30.15_suppl.2525

Abstract #

2525

Poster Bd #

13

Abstract Disclosures

Similar Posters

First Author: S. Phuphanich

First Author: Rongsu Qi

First Author: Richard Eldon Royal

First Author: Roger Tell